Brain Cancer

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses current challenges and opportunities in glioma treatment.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses current challenges and opportunities in glioma treatment.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses how diagnostic techniques for brain cancer are evolving.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses promising new brain cancer treatments.

May is Brain Cancer Awareness Month.

The FDA granted orphan drug designation to WP1122 for the treatment of glioblastoma multiforme, according to a press release from the agent’s manufacturer.

Ashish Shah, MD, has been named director of clinical trials and translational research at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative at University of Miami Miller School of Medicine.

Researchers at Massachusetts General Hospital have developed a new blood test to detect epidermal growth factor receptor mutations in patients with glioma — one of the most common brain cancers in adults.

Glioblastoma, the most common primary brain cancer, is known to be highly aggressive and deadly.

CHICAGO — A combination of two targeted therapies significantly improved outcomes compared with standard care for children with BRAF V600 mutation-positive low-grade glioma, according to study results presented at ASCO Annual Meeting.